Streetbeat News

Stock Prices

SJM

Analysts have provided ratings for JM Smucker (NYSE:SJM) within the last quarter, with 1 bullish, 8 indifferent, and 1 somewhat bearish. The average price target is $155.6, implying an upside from the current price of $139.65. This represents a 1.39% decrease from the previous average price target of $157.80.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:00 pm

CVS

A significant bearish stance has been taken on CVS Health (NYSE:CVS) by a large investor, as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 46% bullish and 53% bearish. The whales have been targeting a price range from $55.0 to $85.0 for CVS Health over the last 3 months. The price of CVS is up 0.43% at $67.09. Several experts have maintained their positive ratings on CVS Health, with price targets ranging from $85 to $110.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:00 pm

VIPS

Vipshop Holdings (NYSE:VIPS) has received mostly bullish ratings from analysts in the last quarter, with an average price target of $17.61, a high of $20.00, and a low of $14.20. The average price target has increased by 13.61% over the past month.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:00 pm

STAA

In the last quarter, Staar Surgical (NASDAQ:STAA) received various analyst ratings, with 3 being bullish, 2 somewhat bullish, and 4 indifferent. The average price target is $58.0, compared to the current price of $42.44, implying an upside. However, this average represents a 12.56% decrease from the previous average price target of $66.33.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 8:00 pm

SPY

Wharton Professor of Finance, Jeremy Siegel, argued that stocks are a better investment than bonds for long-term wealth creation. He stated that the average inflation-adjusted return in the S&P 500 is closer to 6.5%, making it a more lucrative option compared to bonds. He also noted that this strategy is more suitable for investors with a long-term time horizon.

Portfolio Pulse from Adam Eckert

August 21, 2023 | 7:53 pm

AAL

DAL

LUV

UAL

American Airlines Group Inc. has secured a new contract with its pilots, promising an average salary increase of over 21% over four years, with total compensation potentially rising by more than 46%. This comes as airlines face a shortage of pilots and a resurgence in travel demand. The contract includes an immediate 21% pay bump, enhanced sick leave provisions, and other benefits. The deal is worth $9 billion and was approved by 73% of the pilots. Following the announcement, American Airlines' shares saw a 0.7% increase.

Portfolio Pulse from Piero Cingari

August 21, 2023 | 7:53 pm

BILL

Bill Holdings shares are trading lower after gaining last week.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 7:52 pm

ZM

Zoom Video Communications, Inc. (NASDAQ:ZM) shares are trading higher ahead of its Q2 earnings report. The company is expected to report earnings of $1.05 per share and revenue of $1.11 billion. The stock has been affected by various factors recently, including rising COVID-19 concerns, Fitch's downgrade of the U.S. long-term credit rating, and weakness in Netflix and Tesla's quarterly reports. However, it has also benefited from the company's increased technical investments in the Asia-Pacific region.

Portfolio Pulse from Ryan Gustafson

August 21, 2023 | 7:50 pm

MS

A significant bullish stance has been taken on Morgan Stanley (NYSE:MS) by an unknown entity, possibly an institution or a wealthy individual. This was noticed through a large position appearing on publicly available options history. The overall sentiment of these big-money traders is split between 50% bullish and 50% bearish. Whales have been targeting a price range from $75.0 to $92.5 for Morgan Stanley over the last 3 months. Atlantic Equities and Oppenheimer have maintained their Neutral and Outperform ratings on Morgan Stanley, respectively.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:46 pm

ABBV

A significant investor has taken a bearish stance on AbbVie (NYSE:ABBV), with 72% of the spotted trades being bearish. The whales have been targeting a price range from $95.0 to $165.0 for AbbVie over the last 3 months. The current price of ABBV is down -0.55% at $149.32, and RSI indicators suggest that the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 7:45 pm